Clinical Trial Update: R-CHOP14 or R-CHOP21 &Consolidation PET-Oriented Radiotherapy (RT) in DLBCL Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing R-CHOP14 vs R-CHOP21 with consolidation PET-oriented radiotherapy in diffuse large B-cell lymphoma (DLBCL) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-CHOP14
• R-CHOP21

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: COMPLETED